Literature DB >> 3035851

Uterotonic activity and myometrial receptor affinity of 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin.

A Atke, H Vilhardt.   

Abstract

The contractile effect of the analogue 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin (carbetocin) on isolated myometrial strips from rats was compared with that of oxytocin. The uterotonic activity of the analogue was 15 +/- 3 IU/mg as compared with 438 +/- 41 for oxytocin, however, the response was more prolonged and could not be abolished by washing of the preparation. Despite the low biological activity of carbetocin, its binding affinity to receptors of isolated myometrial plasma membranes was of the same order of magnitude as that of oxytocin. On the basis of the present results it is concluded that a longer half-life of the analogue at the receptor compartment may be a contributing factor to the prolonged uterotonic effect observed in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035851     DOI: 10.1530/acta.0.1150155

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour.

Authors:  S W Leung; P S Ng; W Y Wong; T H Cheung
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

2.  Carbetocin vs. Syntometrine in Prevention of Postpartum Hemorrhage: a Double Blind Randomized Control Trial.

Authors:  Mansoureh Samimi; Azam Imani-Harsini; Masoumeh Abedzadeh-Kalahroudi
Journal:  Iran Red Crescent Med J       Date:  2013-09-05       Impact factor: 0.611

3.  Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β-Arrestin-Independent Internalisation.

Authors:  I Passoni; M Leonzino; V Gigliucci; B Chini; M Busnelli
Journal:  J Neuroendocrinol       Date:  2016-04       Impact factor: 3.627

4.  Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development.

Authors:  Sarah Arrowsmith; Peter Keov; Markus Muttenthaler; Christian W Gruber
Journal:  J Vis Exp       Date:  2018-01-26       Impact factor: 1.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.